Browse Category

NASDAQ:MSPR News 3 November 2025 - 17 November 2025

MSP Recovery (MSPR) Stock Jumps Over 20% Pre‑Market as Q3 Delay and Nasdaq Fight Keep Volatility High – 17 November 2025

MSP Recovery (MSPR) Stock Jumps Over 20% Pre‑Market as Q3 Delay and Nasdaq Fight Keep Volatility High – 17 November 2025

Important: This article is news and analysis, not investment advice. MSPR is a highly speculative micro‑cap; anyone considering it should do independent research and consider professional guidance. What’s Happening With MSPR Today (17 November 2025)? Pre‑market spike puts MSPR back on trader radars In the very early hours of Monday’s U.S. session, Benzinga’s pre‑market movers roundup flagged MSP Recovery as one of the most aggressive gainers in the market. At about 4:42 a.m. ET, the outlet reported MSPR up 38.6% to $0.6230 in pre‑market trading, noting that the stock had fallen roughly 5% on Friday. A few hours later, Benzinga’s
17 November 2025
MSP Recovery (MSPR) rockets pre‑market on heavy volume as traders eye earnings timing and Nasdaq listing fight — Nov. 11, 2025

MSP Recovery (MSPR) rockets pre‑market on heavy volume as traders eye earnings timing and Nasdaq listing fight — Nov. 11, 2025

MSP Recovery, Inc. (NASDAQ: MSPR) — also known as LifeWallet — swung wildly in Tuesday’s pre‑market, at one point topping the list of healthcare gainers on heavy volume as investors weighed conflicting earnings‑calendar signals and the company’s ongoing bid to avert a Nasdaq delisting. What happened today (Nov. 11, 2025) Bottom line: Depending on the timestamp, different pre‑market dashboards painted opposite pictures — a common quirk in micro‑cap names with surging off‑hours volume. Always check the latest prints and times attached to each data source. Why the spike? Earnings calendar confusion + micro‑cap flows Today’s snapshot (as of publication) (Note:
MSP Recovery (MSPR) Stock Skyrockets 100% Amid Delisting Drama – What’s Next for This Troubled Company?

MSP Recovery (MSPR) Stock Skyrockets 100% Amid Delisting Drama – What’s Next for This Troubled Company?

In short: MSP Recovery’s stock is trading at mere pennies after a spectacular rise-and-fall on Nov 3. The company is fighting for survival – juggling emergency financings, a looming Nasdaq delisting, and ongoing legal battles – all while attempting to transform its fortunes in the healthcare reimbursement industry. Company Overview: Business Model & Financials Business Model: MSP Recovery, Inc. is a 2014-founded Miami-based company that aims to recover reimbursements from Medicare, Medicaid, and other insurers on behalf of healthcare payerstipranks.com. Under the Medicare Secondary Payer (MSP) Act, if a private insurer should have paid a claim that Medicare/Medicaid covered, that
3 November 2025

Stock Market Today

Tower Semiconductor stock jumps again on Nvidia optics tie-up as earnings near

Tower Semiconductor stock jumps again on Nvidia optics tie-up as earnings near

8 February 2026
Tower Semiconductor shares rose 7.7% to $139.04 Friday after announcing a collaboration with Nvidia on AI data-center networking. The stock touched $141 intraday and gained another 1% after hours. Investors await Tower’s Feb. 11 earnings for details on its silicon photonics work. No financial terms or shipment timeline were disclosed.
Longsys Electronics stock heads into Monday after new guarantees; what 301308 investors watch next

Longsys Electronics stock heads into Monday after new guarantees; what 301308 investors watch next

8 February 2026
Longsys disclosed new guarantees for a 100 million yuan Hong Kong loan and a $9 million Brazil credit line, bringing its total approved guarantee quota to 11 billion yuan and outstanding guarantees to 5.81 billion yuan. The company said all guarantees are for consolidated subsidiaries and within approved limits. Shares closed at 288 yuan Friday, down 1.6%. China inflation and credit data are due this week.
MACOM stock price steadies near highs into Monday after earnings pop and fresh filings

MACOM stock price steadies near highs into Monday after earnings pop and fresh filings

8 February 2026
MACOM shares rose 3.5% to $235.87 Friday after the company reported fiscal Q1 revenue of $271.6 million and raised its full-year data center growth outlook to 35–40%. Fidelity’s FMR LLC disclosed a 10.7% stake, while shareholder Susan Ocampo filed to potentially sell up to 100,000 shares. Stifel raised its price target to $255. MACOM expects to repay $161 million in convertible notes in March.
Go toTop